Pregled bibliografske jedinice broj: 1274187
Early Assessment of Neoadjuvant Chemotherapy Response Using Multiparametric Magnetic Resonance Imaging in Luminal B-like Subtype of Breast Cancer Patients: A Single-Center Prospective Study
Early Assessment of Neoadjuvant Chemotherapy Response Using Multiparametric Magnetic Resonance Imaging in Luminal B-like Subtype of Breast Cancer Patients: A Single-Center Prospective Study // Diagnostics, 13 (2023), 4; 694, 11 doi:10.3390/diagnostics13040694 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1274187 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Early Assessment of Neoadjuvant Chemotherapy
Response Using Multiparametric Magnetic Resonance
Imaging in Luminal B-like Subtype of Breast Cancer
Patients: A Single-Center Prospective Study
Autori
Kovačević, Lucija ; Petrovečki, Marko ; Korša, Lea ; Marušić, Zlatko ; Dumić-Čule, Ivo ; Prutki, Maja
Izvornik
Diagnostics (2075-4418) 13
(2023), 4;
694, 11
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
breast cancer ; multiparametric magnetic resonance imaging ; neoadjuvant therapy
Sažetak
This study aimed to evaluate the performance of multiparametric breast magnetic resonance imaging (mpMRI) for predicting response to neoadjuvant chemotherapy (NAC) in patients with luminal B subtype breast cancer. The prospective study included thirty-five patients treated with NAC for both early and locally advanced breast cancer of the luminal B subtype at the University Hospital Centre Zagreb between January 2015 and December 2018. All patients underwent breast mpMRI before and after two cycles of NAC. Evaluation of mpMRI examinations included analysis of both morphological (shape, margins, and pattern of enhancement) and kinetic characteristics (initial signal increase and post-initial behavior of the time-signal intensity curve), which were additionally interpreted with a Göttingen score (GS). Histopathological analysis of surgical specimens included grading the tumor response based on the residual cancer burden (RCB) grading system and revealed 29 NAC responders (RCB-0 (pCR), I, II) and 6 NAC non-responders (RCB-III). Changes in GS were compared with RCB classes. A lack of GS decrease after the second cycle of NAC is associated with RCB class and non-responders to NAC.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb,
Sveučilište Sjever, Koprivnica
Profili:
Ivo Dumić-Čule
(autor)
Maja Prutki
(autor)
Zlatko Marušić
(autor)
Lucija Kovačević
(autor)
Lea Korša
(autor)
Marko Petrovečki
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus